Plain-English translation of NCT06021808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Atrial fibrillation is a common heart rhythm disorder that significantly increases your stroke risk. This trial is testing whether a newer surgical approach called thoracoscopic left atrial appendage clipping—a minimally invasive procedure that seals off a small pouch in the heart where blood clots often form—works as well as or better than taking NOACs (novel oral anticoagulants), the standard blood thinner medications prescribed for this condition.
Many patients with atrial fibrillation struggle with long-term blood thinner therapy because of side effects, bleeding risks, or difficulty remembering to take pills daily. Researchers want to see if this surgical approach offers a safer, more reliable alternative for preventing strokes in people who cannot tolerate or stay consistent with medication.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the surgery group, you will undergo a thoracoscopic left atrial appendage clipping procedure and then be monitored over time to see if you have any strokes or complications. If you are assigned to the medication group, you will take daily blood thinner pills (NOACs) immediately after enrollment and continue them long-term while being followed. Both groups will have regular check-ins to track your health and watch for any adverse events over the study period.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China